BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 28505188)

  • 1. Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection.
    Pittman JE; Noah H; Calloway HE; Davis SD; Leigh MW; Drumm M; Sagel SD; Accurso FJ; Knowles MR; Sontag MK
    PLoS One; 2017; 12(5):e0177215. PubMed ID: 28505188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulatory effect of the SLC9A3 gene on susceptibility to infections and pulmonary function in children with cystic fibrosis.
    Dorfman R; Taylor C; Lin F; Sun L; Sandford A; Paré P; Berthiaume Y; Corey M; Durie P; Zielenski J;
    Pediatr Pulmonol; 2011 Apr; 46(4):385-92. PubMed ID: 20967843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Viel M; Hubert D; Burgel PR; Génin E; Honoré I; Martinez B; Gaitch N; Chapron J; Kanaan R; Dusser D; Girodon E; Bienvenu T
    Clin Respir J; 2016 Nov; 10(6):777-783. PubMed ID: 25763772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The determinants of survival among adults with cystic fibrosis-a cohort study.
    Durda-Masny M; Goździk-Spychalska J; John A; Czaiński W; Stróżewska W; Pawłowska N; Wlizło J; Batura-Gabryel H; Szwed A
    J Physiol Anthropol; 2021 Nov; 40(1):19. PubMed ID: 34749804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Pseudomonas aeruginosa infection and respiratory muscle impairment in cystic fibrosis.
    Dassios TG; Katelari A; Doudounakis S; Dimitriou G
    Respir Care; 2014 Mar; 59(3):363-70. PubMed ID: 23983273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
    Parad RB; Gerard CJ; Zurakowski D; Nichols DP; Pier GB
    Infect Immun; 1999 Sep; 67(9):4744-50. PubMed ID: 10456926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
    Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
    Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in lung clearance index with microbiological status in children with cystic fibrosis.
    Walicka-Serzysko K; Postek M; Milczewska J; Sands D
    Pediatr Pulmonol; 2019 Jun; 54(6):729-736. PubMed ID: 30838817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
    Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
    JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Pseudomonas aeruginosa infection stage with lung function trajectory in children with cystic fibrosis.
    Rosenfeld M; Faino AV; Qu P; Onchiri FM; Blue EE; Collaco JM; Gordon WW; Szczesniak R; Zhou YH; Bamshad MJ; Gibson RL
    J Cyst Fibros; 2023 Sep; 22(5):857-863. PubMed ID: 37217389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for the progression of cystic fibrosis lung disease throughout childhood.
    Sanders DB; Li Z; Laxova A; Rock MJ; Levy H; Collins J; Ferec C; Farrell PM
    Ann Am Thorac Soc; 2014 Jan; 11(1):63-72. PubMed ID: 24261460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.
    Nixon GM; Armstrong DS; Carzino R; Carlin JB; Olinsky A; Robertson CF; Grimwood K
    J Pediatr; 2001 May; 138(5):699-704. PubMed ID: 11343046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal screening of cystic fibrosis: diagnostic problems with CFTR mild mutations.
    Roussey M; Le Bihannic A; Scotet V; Audrezet MP; Blayau M; Dagorne M; David V; Deneuville E; Giniès JL; Laurans M; Moisan-Petit V; Rault G; Vigneron P; Férec C
    J Inherit Metab Dis; 2007 Aug; 30(4):613. PubMed ID: 17632692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.
    Limoli DH; Yang J; Khansaheb MK; Helfman B; Peng L; Stecenko AA; Goldberg JB
    Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):947-53. PubMed ID: 26993289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial.
    Wainwright CE; Vidmar S; Armstrong DS; Byrnes CA; Carlin JB; Cheney J; Cooper PJ; Grimwood K; Moodie M; Robertson CF; Tiddens HA;
    JAMA; 2011 Jul; 306(2):163-71. PubMed ID: 21750293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of birth order and age at diagnosis in cystic fibrosis: a sibling cohort study.
    Slieker MG; van den Berg JM; Kouwenberg J; van Berkhout FT; Heijerman HG; van der Ent CK
    Pediatr Pulmonol; 2010 Jun; 45(6):601-7. PubMed ID: 20503286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology and management of pulmonary infections in cystic fibrosis.
    Gibson RL; Burns JL; Ramsey BW
    Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
    Ren CL; Desai H; Platt M; Dixon M
    Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Italian Cystic Fibrosis Register - Report 2010].
    Amato A; Ferrigno L; Salvatore M; Toccaceli V;
    Epidemiol Prev; 2016; 40(2 Suppl 2):1-47. PubMed ID: 27291389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.